Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents

Acta Otolaryngol. 2011 Oct;131(10):1025-31. doi: 10.3109/00016489.2011.598552. Epub 2011 Jul 6.

Abstract

Conclusion: Imaging of the endolymphatic space was possible in most cases after administering a standard dose of gadolinium (Gd) by using heavily T2-weighted 3D fluid-attenuated inversion recovery (hT(2)W-3D-FLAIR) magnetic resonance imaging (MRI).

Objectives: The aim of this study was to characterize the contrast enhancement in the inner ear after intravenous injection of Gd and to compare the signal intensity after a double dose or standard dose of Gd.

Methods: We injected a standard dose of gadodiamide hydrate (DTPA-BMA) or a double dose of gadoteridol (HP-DO3A) intravenously in patients affected by Meniere's disease and performed hT(2)W-3D-FLAIR 3 T MRI. Contrast enhancement of the basal turn of the cochlea was evaluated semiquantitatively.

Results: Endolymphatic hydrops was observed in the cochlea and vestibule of the affected ears of patients with Meniere's disease in both the double-dose group and the standard-dose group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Contrast Media* / administration & dosage
  • Female
  • Gadolinium DTPA* / administration & dosage
  • Gadolinium* / administration & dosage
  • Heterocyclic Compounds* / administration & dosage
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Meniere Disease / pathology*
  • Middle Aged
  • Organometallic Compounds* / administration & dosage
  • Perilymph*
  • Young Adult

Substances

  • Contrast Media
  • Heterocyclic Compounds
  • Organometallic Compounds
  • gadoteridol
  • gadodiamide
  • Gadolinium
  • Gadolinium DTPA